AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC (EIN 522340031) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2001

Legal Domicile

Phone

2026615700

Tax Period

2025-01-01 to 2025-03-31

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC, founded in 2001, is a mid-sized nonprofit in the Medical Research sector that reported $11.5M in total revenue in fiscal year 2024. Revenue fell 77% from the prior year — a significant decline worth monitoring.

Mission

ACS CAN ADVOCATES FOR EVIDENCE-BASED PUBLIC POLICIES TO REDUCE THE CANCER BURDEN FOR EVERYONE AS THE NONPROFIT, NONPARTISAN ADVOCACY AFFILIATE OF AMERICAN CANCER SOCIETY INC.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $11,355,484

Program Service Revenue $0

Investment Income $0

Other Revenue $148,274

TOTAL REVENUE $11,503,758

Expense Breakdown

Grants Paid $505,085

Salaries & Benefits $8,018,248

Fundraising Expenses $408,849

Program Expenses $11,606,017

Other Expenses $3,883,907

TOTAL EXPENSES $12,407,240

Year-over-Year Comparison

	2024	2023	Change
Revenue	$11,503,758	$49,827,894	-0.8%
Expenses	$12,407,240	$53,122,392	-0.8%
Net Income	$-903,482	$-3,294,498	-0.7%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✓ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

39829

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JOHN J MANNA JR ESQ	BOARD VICE CHAIR	5.0	Officer Director	$0	$0	$0
KAY COLEMAN	BOARD TREASURER	5.0	Officer Director	$0	$0	$0
KIMBERLY L JEFFRIES LEONARD PHD	BOARD CHAIR	8.0	Officer Director	$0	$0	$0
MAUREEN G MANN MS MBA FACHE	BOARD IMMEDIATE PAST CHAIR	5.0	Officer Director	$0	$0	$0
SCARLOTT K MUELLER MPH RN FAAN	BOARD SECRETARY	5.0	Officer Director	$0	$0	$0
BRIAN A MARLOW CFA	ACS BOARD CHAIR	3.0	Director	$0	$0	$0
BRUCE D WALDHOLTZ MD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
DANA BERNSON MPH	BOARD DIRECTOR	3.0	Director	$0	$0	$0
DAVID FORD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
DAVID O GARCIA PHD FACSM	BOARD DIRECTOR	3.0	Director	$0	$0	$0
JOSE R RAMOS JR	BOARD DIRECTOR	3.0	Director	$0	$0	$0
KAREN WINKFIELD MD PHD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
MARGARET MCCAFFERY JD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
OMAR M RASHID MD JD FACS FSSO DABS	BOARD DIRECTOR	3.0	Director	$0	$0	$0
PHILIP R O'BRIEN	BOARD DIRECTOR	3.0	Director	$0	$0	$0
SUSAN PENFIELD	BOARD DIRECTOR	3.0	Director	$0	$0	$0
KAEL REICIN	CHIEF FINANCIAL & STRATEGY OFFICER	5.0	Officer	$0	$0	$0
LISA A LACASSE	PRESIDENT	55.0	Officer	$0	$0	$0
WAYNE A I FREDERICK MD MBA FACS	INTERIM CEO	5.0	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$11,503,758	$12,407,240	$20,457,771	$-903,482
2024	No data	No data	No data	No data
2023	$45,517,184	$49,005,138	$25,851,271	$-3,487,954
2022	$45,971,886	$41,807,800	$29,345,550	$4,164,086
2021	$34,082,078	$30,260,755	$18,877,884	$3,821,323
2020	$32,015,639	$27,713,763	$13,099,092	$4,301,876
2019	$37,833,806	$39,276,756	$8,697,938	$-1,442,950
2018	$37,948,021	$35,069,264	$11,587,587	$2,878,757

AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC